Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市场动荡和不确定时期，许多投资者转向股息收益率股票。这些公司通常具有较高的自由现金流，并以高额的股息支付来奖励股东。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的读者可以通过访问我们的分析师股票评级页面来查看分析师对他们最喜欢的股票的最新看法。交易者可以对Benzinga庞大的分析师评级数据库进行排序，包括按分析师的准确性进行排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是最准确的分析师对医疗保健行业三只高收益股票的评级。
Pfizer Inc. (NYSE:PFE)
辉瑞公司（纽约证券交易所代码：PFE）
- Dividend Yield: 5.96%
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and increased the price target from $28 to $29 on May 2. This analyst has an accuracy rate of 70%.
- BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and raised the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 68%.
- Recent News: Pfizer has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks associated with its Zantac heartburn medication, marking the largest resolution in the litigation.
- 股息收益率：5.96%
- 摩根士丹利分析师特伦斯·弗林维持同等权重评级，并于5月2日将目标股价从28美元上调至29美元。该分析师的准确率为70％。
- BMO Capital分析师埃文·戴维·塞格曼重申了跑赢大盘的评级，并于5月2日将目标股价从33美元上调至36美元。该分析师的准确率为68％。
- 最近的新闻：据报道，辉瑞已经和解了10,000起诉讼，指控其隐瞒了与Zantac胃灼热药物相关的癌症风险，这是该诉讼中最大的解决方案。
Organon & Co. (NYSE:OGN)
Organon & Co.（纽约证券交易所代码：OGN）
- Dividend Yield: 5.46%
- Piper Sandler analyst DavidAmsellemmaintained an Overweight rating and raised the price target from $22 to $24 on April 29. This analyst has an accuracy rate of 66%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $27 to $22 on Oct. 11, 2023. This analyst has an accuracy rate of 70%.
- Recent News: Organon announced pricing of $1.0 billion senior notes offering.
- 股息收益率：5.46%
- 派珀·桑德勒分析师戴维达姆塞勒维持增持评级，并于4月29日将目标股价从22美元上调至24美元。这位分析师的准确率为66％。
- 摩根士丹利分析师特伦斯·弗林维持同等权重评级，并于2023年10月11日将目标股价从27美元下调至22美元。该分析师的准确率为70％。
- 最新消息：Organon宣布了10亿美元优先票据发行的定价。
Bristol-Myers Squibb Company (NYSE:BMY)
百时美施贵宝公司（纽约证券交易所代码：BMY）
- Dividend Yield: 5.36%
- BMO Capital analyst Evan Siegermanmaintained a Market Perform rating and cut the price target from $55 to $48 on April 26. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $51 to $52 on April 18. This analyst has an accuracy rate of 77%.
- Recent News: On April 25, Bristol Myers Squibb posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion.
- 股息收益率：5.36%
- BMO Capital分析师埃文·西格曼维持市场表现评级，并于4月26日将目标股价从55美元下调至48美元。这位分析师的准确率为60％。
- 富国银行分析师莫希特·班萨尔维持同等权重评级，并于4月18日将目标股价从51美元上调至52美元。这位分析师的准确率为77％。
- 最新消息：4月25日，百时美施贵宝公布的第一季度收入为119亿美元，超过了市场普遍预期的115亿美元。
Read More: Enbridge, Funko And 3 Stocks To Watch Heading Into Friday
阅读更多：进入周五，Enbridge、Funko和3只股票值得关注